HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The prognostic significance of nuclear DNA content in chondrosarcoma.

Abstract
The nuclear DNA content in 48 chondrosarcomas and 4 chondromas was determined. Grading according to O'Neal-Ackerman was also performed. All chondromas were found to be diploid (normal nuclear DNA content). Twenty-two of the chondrosarcomas showed the same DNA distribution curve as the chondromas and were characterized as diploid, while 26 were found to be hyperploid (increased nuclear DNA content). A comparative study of grade and ploidy in relation to ten-year survival and metastasis rates showed that ploidy determinations in chondrosarcomas give significant prognostic information, even better than that obtained by conventional histopathologic grading. In this study, diploid chondrosarcomas were found to be associated with a significantly more favorable clinical course than were hyperploid chondrosarcomas. The prognostic relevance of these ploidy determination was further confirmed by analyzing the ploidy level of selected cases characterized bydifferent clinical courses. Thus, the tumors from 13 (93%) of 14 patients with a highly malignant clinical course (death within two years) and the tumors at the primary site in 17 (81%) of 21 metastasizing chondrosarcomas were found to be hyperploid. Direct measurements on four metastases revealed that all were hyperploid.
AuthorsA Kreicbergs, A Zetterberg, G Söderberg
JournalAnalytical and quantitative cytology (Anal Quant Cytol) Vol. 2 Issue 4 Pg. 272-9 (Dec 1980) ISSN: 0190-0471 [Print] United States
PMID7469202 (Publication Type: Journal Article)
Chemical References
  • DNA, Neoplasm
Topics
  • Adolescent
  • Adult
  • Aged
  • Aneuploidy
  • Bone Neoplasms (analysis)
  • Child
  • Chondroma (analysis, pathology)
  • Chondrosarcoma (analysis, pathology)
  • DNA, Neoplasm (analysis)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polyploidy
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: